Register to chat with like-minded investors on our interactive forums.
Period:
Draw Mode:
| Volume | 271,784 |
|
|||||
| News | - | ||||||
| Day High | 8.63 | Low High |
|||||
| Day Low | 8.00 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Outlook Therapeutics Inc | OTLK | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.11 | -1.33% | 8.18 | 20:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 8.28 | 8.00 | 8.63 | 8.17 | 8.29 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 2,381 | 271,784 | $ 8.21 | $ 2,230,679 | - | 4.004 - 40.60 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:37:17 | 30 | $ 8.00 | USD |
Outlook Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 106.32M | 13.01M | - | 0 | -58.98M | -4.53 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Outlook Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical OTLK Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 9.03 | 9.26 | 8.00 | 8.59 | 256,902 | -0.85 | -9.41% |
| 1 Month | 10.77 | 12.8499 | 7.70 | 8.98 | 1,685,256 | -2.59 | -24.05% |
| 3 Months | 8.80 | 12.8499 | 5.0401 | 8.47 | 1,539,745 | -0.62 | -7.05% |
| 6 Months | 10.20 | 18.00 | 5.00 | 9.87 | 4,121,660 | -2.02 | -19.80% |
| 1 Year | 22.00 | 40.60 | 4.004 | 10.79 | 4,084,453 | -13.82 | -62.82% |
| 3 Years | 35.60 | 65.40 | 4.004 | 20.27 | 2,136,368 | -27.42 | -77.02% |
| 5 Years | 31.60 | 85.20 | 4.004 | 26.57 | 2,145,409 | -23.42 | -74.11% |
Outlook Therapeutics Description
| Outlook Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications. |
